{"id":1350710,"title":"DSEN Abstract: Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-19","captureTimestamp":"2026-02-19T20:00:17.758000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52727.html?wbdisable=true","snippet":"DSEN Abstract Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia In the treatment of chronic hepatitis C, ribavirin is often incorporated to improve treatment effectiveness. However, 1 in 3 treated patients develop severe anemia. This study…","rawSnapshotUrl":"/api/snapshots/raw/1350710","browseUrl":"https://replay.healtharchive.ca/job-8/20260219200017/https://cihr-irsc.gc.ca/e/52727.html?wbdisable=true#ha_snapshot=1350710","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}